CoChat

Predictors of serious adverse events and non‐response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid

Open access
De Vincentis, Antonio, D'Amato, Daphne, Cristoferi, Laura, Gerussi, Alessio, Malinverno, Federica, Lleo, Ana, Colapietro, Francesca, Marra, Fabio, Galli, Andrea, Fiorini, Cecilia, Coco, Barbara, Brunetto, Maurizia, Niro, Grazia Anna, Cotugno, Rosa, Saitta, Carlo, Cozzolongo, Raffaele, Losito, Francesco, Giannini, Edoardo Giovanni, Labanca, Sara, Marzioni, Marco, Marconi, Giulia, Morgando, Anna, Pellicano, Rinaldo, Vanni, Ester, Cazzagon, Nora, Floreani, Annarosa, Chessa, Luchino, Morelli, Olivia, Muratori, Luigi, Pellicelli, Adriano, Pompili, Maurizio, Ponziani, Francesca, Tortora, Annalisa, Rosina, Floriano, Russello, Maurizio, Cannavò, Mariarita, Simone, Loredana, Storato, Silvia, Viganò, Mauro, Abenavoli, Ludovico, D'Antò, Maria, De Gasperi, Elisabetta, Distefano, Marco, Scifo, Gaetano, Zolfino, Teresa, Calvaruso, Vincenza, Cuccorese, Giuseppe, Palitti, Valeria Pace, Sacco, Rodolfo, Bertino, Gaetano, Frazzetto, Evelise, Alvaro, Domenico, Mulinacci, Giacomo, Palermo, Andrea, Scaravaglio, Miki, Terracciani, Francesca, Galati, Giovanni, Ronca, Vincenzo, Zuin, Massimo, Claar, Ernesto, Izzi, Antonio, Picardi, Antonio, Invernizzi, Pietro, Vespasiani‐Gentilucci, Umberto, Carbone, Marco, on behalf of the Club Epatologi Ospedalieri (CLEO)/Associazione Italiana Gastroenterologi ed Endoscopisti Digestivi Ospedalieri (AIGO) PBC Study Group and, the Italian PBC Registry · 2022 · Liver International
Cited by 30

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

Background & Aims: Obeticholic acid (OCA) has recently been restricted in patients with primary biliary cholangitis (PBC) with “advanced cirrhosis” because of its narrow therapeutic index. We aimed to better define the predicting factors of hepatic serious adverse events (SAEs) and non‐response in cirrhotic patients undergoing OCA therapy. Methods: Safety and efficacy of treatment were evaluated in a cohort of consecutive PBC cirrhotic patients started with OCA. OCA response was evaluated according to the Poise criteria. Risk factors for hepatic SAEs and non‐response were reported as risk ratios (RR) with 95% confidence intervals (CIs). Results: One hundred PBC cirrhotics were included, 97 Child‐Pugh class A and 3 class B. Thirty‐one had oesophageal varices and 5 had a history of ascites. Thirty‐three per cent and 32% of patients achieved a biochemical response at 6 and 12 months respectively. Male sex (adjusted‐RR 1.75, 95%CI 1.42–2.12), INR (1.37, 1.00–1.87), Child‐Pugh score (1.79, 1.28–2.50), MELD (1.17, 1.04–1.30) and bilirubin (1.83, 1.11–3.01) were independently associated with non‐response to OCA. Twenty‐two patients discontinued OCA within 12 months: 10 for pruritus, 9 for hepatic SAEs (5 for jaundice and/or ascitic decompensation; 4 for upper digestive bleeding). INR (adjusted‐RR 1.91, 95%CI 1.10–3.36), lower albumin levels (0.18, 0.06–0.51), Child‐Pugh score (2.43, 1.50–4.04), history of ascites (3.5, 1.85–6.5) and bilirubin (1.30, 1.05–1.56), were associated with hepatic SAEs. A total bilirubin≥1.4 mg/dl at baseline was the most accurate biochemical predictor of hepatic SAEs under OCA. Conclusions: An accurate baseline assessment is crucial to select cirrhotic patients who can benefit from OCA. Although OCA is effective in one third of cirrhotics, bilirubin level ≥1.4 mg/dl should discourage from its use.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/liv.15386

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

See all 30

Metadata

Authors
De Vincentis, A., D'Amato, D., Cristoferi, L., Gerussi, A., Malinverno, F., Lleo, A., Colapietro, F., Marra, F., Galli, A., Fiorini, C., Coco, B., Brunetto, M., Niro, G. A., Cotugno, R., Saitta, C., Cozzolongo, R., Losito, F., Giannini, E. G., Labanca, S., Marzioni, M., Marconi, G., Morgando, A., Pellicano, R., Vanni, E., Cazzagon, N., Floreani, A., Chessa, L., Morelli, O., Muratori, L., Pellicelli, A., Pompili, M., Ponziani, F., Tortora, A., Rosina, F., Russello, M., Cannavò, M., Simone, L., Storato, S., Viganò, M., Abenavoli, L., D'Antò, M., De Gasperi, E., Distefano, M., Scifo, G., Zolfino, T., Calvaruso, V., Cuccorese, G., Palitti, V. P., Sacco, R., Bertino, G., Frazzetto, E., Alvaro, D., Mulinacci, G., Palermo, A., Scaravaglio, M., Terracciani, F., Galati, G., Ronca, V., Zuin, M., Claar, E., Izzi, A., Picardi, A., Invernizzi, P., Vespasiani‐Gentilucci, U., Carbone, M., & on behalf of the Club Epatologi Ospedalieri (CLEO)/Associazione Italiana Gastroenterologi ed Endoscopisti Digestivi Ospedalieri (AIGO) PBC Study Group and, T. I. P. R.
Venue
Liver International
Publisher
Wiley
Published
2022-08-23
Volume
42
Issue
11
Pages
2453-2465
ISSN
  • 0106-9543 (ISSN-L)
  • 1478-3223
  • 1478-3231
OpenAlex
W4289929856
Cited by
30
References
11
FWCI
3.19
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Predictors of serious adverse events and non‐response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid. https://app.cochat.ai/papers/10.1111/liv.15386
The paper
De Vincentis, A., D'Amato, D., Cristoferi, L., Gerussi, A., Malinverno, F., Lleo, A., Colapietro, F., Marra, F., Galli, A., Fiorini, C., Coco, B., Brunetto, M., Niro, G. A., Cotugno, R., Saitta, C., Cozzolongo, R., Losito, F., Giannini, E. G., Labanca, S., . . . on behalf of the Club Epatologi Ospedalieri (CLEO)/Associazione Italiana Gastroenterologi ed Endoscopisti Digestivi Ospedalieri (AIGO) PBC Study Group and, T. I. P. R. (2022). Predictors of serious adverse events and non‐response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid. Liver International. https://doi.org/10.1111/liv.15386

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.